CLLS = 1.86 US dollar
+0.035 USD (+1.88%)
change of stock price since yesterday
The stock price of Cellectis S.A. in US dollar at the last deal. The stock quote price has an average value per day. Stock price from verified sources. 1 stock of Cellectis S.A. is 1.86 US dollar. The cost of 1 stock of Cellectis S.A. is now equal to 1.86 US dollar. The Cellectis S.A. stock price increased in US dollar by 192 hundredths of a percentage point. |
||||||||||||||||||||
|
||||||||||||||||||||
Cellectis S.A. share price in US dollarA month ago, Cellectis S.A. stock could be bought for 0 US dollar. Six months ago, Cellectis S.A. stock can be exchanged for 0 US dollar. A year ago, Cellectis S.A. stock could be sold for 1.97 stock of US dollar. Here is shown a chart of the stock price for different times. -4.12% per week - the change in the stock price of Cellectis S.A.. Over the month, Cellectis S.A. in US dollar stock price changed by 0%. |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
Stock quotes Cellectis S.A. US dollar
If you have 10 stocks of Cellectis S.A., then in the British Virgin Islands they can be sold for 18.60 US dollar. Today 46.50 USD = 25 stocks of CLLS. Today, 50 stocks of Cellectis S.A. can be sold for 93 US dollar. You can exchange 100 stocks of Cellectis S.A. for 186 US dollar. Stock quote converter now gives 465 US dollar for 250 stocks of Cellectis S.A.. Today 500 stocks of CLLS = 930 USD. |
CLLS stock price history
Today 500 stocks of CLLS = 1.86 USD. 2 May 2023, 1 stock of Cellectis S.A. = 1.83 US dollar. Cellectis S.A. stock price in US dollar on 1 May 2023 is equal to 1.95 US dollar. The maximum stock quote of Cellectis S.A. in US dollar in was on 01/05/2023. The minimum Cellectis S.A. stock quote in US dollar for the last month was on 02/05/2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellectis S.A.Today's stock price of Cellectis S.A. is 1.86 $. CLLS stock price changed by +1.88% or +0.035 USD since last trading day. You can buy 100 CLLS stocks for 186 US dollar or sell 50 CLLS stocks for 93 US dollar. Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|